The gut microbiome as possible mediator of the beneficial effects of very low calorie ketogenic diet on type 2 diabetes and obesity: a narrative review.


Journal

Eating and weight disorders : EWD
ISSN: 1590-1262
Titre abrégé: Eat Weight Disord
Pays: Germany
ID NLM: 9707113

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 06 03 2022
accepted: 11 06 2022
pubmed: 1 7 2022
medline: 15 10 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

Several studies have shown a strong correlation between the different types of diets and gut microbiota composition on glycemia and weight loss. In this direction, low-carbohydrate and ketogenic diets have gained popularity, despite studies published so far leading to controversial results on subjects with diabetes. In this narrative review, firstly, we aimed to analyze the role of very-low-calorie ketogenic diets (VLCKDs) in type 2 diabetes (T2DM) and obesity management. Secondly, in this context, we focused attention on gut microbiota as a function of VLCKD, particularly in T2DM and obesity treatment. Finally, we reported all this evidence to underline the importance of gut microbiota to exalt new nutritional strategies for "tailor-made" management, treatment, and rehabilitation in subjects with T2DM and obesity, even with diabetic complications. In conclusion, this narrative review outlined the beneficial impact of VLCKD on gut microbiota even in subjects with T2DM and obesity, and, despite inner VLCKD short-duration feature allowing no sound-enough provisions for long-term outcomes, witnessed in favor of the short-term safety of VLCKD in those patients.Level of evidence Level V: Opinions of authorities, based on descriptive studies, narrative reviews, clinical experience, or reports of expert committees.

Identifiants

pubmed: 35773554
doi: 10.1007/s40519-022-01434-2
pii: 10.1007/s40519-022-01434-2
doi:

Substances chimiques

Blood Glucose 0
Ketone Bodies 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2339-2346

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ (2022) IDF diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https://doi.org/10.1016/j.diabres.2021.109119 (Epub 2021 Dec 6 PMID: 34879977)
doi: 10.1016/j.diabres.2021.109119 pubmed: 34879977
WHO https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight . Access on Feb 2022
American Diabetes Association Professional Practice Committee (2022) 8 Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of medical care in diabetes—2022. Diabetes Care 45(1):113–124. https://doi.org/10.2337/dc22-S008
doi: 10.2337/dc22-S008
Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M, American Diabetes Association Professional Practice Committee; American Diabetes Association Professional Practice Committee (2022) 9 pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022. Diabetes Care. https://doi.org/10.2337/dc22-Sint
doi: 10.2337/dc22-Sint pubmed: 34964887
Defeudis G, Khazrai YM, Di Rosa C, Secchi C, Montedoro A, Maurizi AR, Palermo A, Pozzilli P, Manfrini S (2018) Conversation Maps™, an effective tool for the management of males and females with type 2 diabetes and mildly impaired glycemic control. Hormones (Athens). https://doi.org/10.1007/s42000-018-0005-9
doi: 10.1007/s42000-018-0005-9
Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, Donini LM, Basciani S, Cignarelli A, Conte E, Ceccarini G, Bogazzi F, Cimino L, Condorelli RA, La Vignera S, Calogero AE, Gambineri A, Vignozzi L, Prodam F, Aimaretti G, Linsalata G, Buralli S, Monzani F, Aversa A, Vettor R, Santini F, Vitti P, Gnessi L, Pagotto U, Giorgino F, Colao A, Lenzi A, Cardiovascular Endocrinology Club of the Italian Society of Endocrinology (2019) Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest 42(11):1365–1386. https://doi.org/10.1007/s40618-019-01061-2
doi: 10.1007/s40618-019-01061-2 pubmed: 31111407
Moriconi E, Camajani E, Fabbri A, Lenzi A, Caprio M (2021) Very-low-calorie ketogenic diet as a safe and valuable tool for long-term glycemic management in patients with obesity and type 2 diabetes. Nutrients 13(3):758. https://doi.org/10.3390/nu13030758
doi: 10.3390/nu13030758 pubmed: 33652834 pmcid: 7996853
Watanabe M, Tuccinardi D, Ernesti I, Basciani S, Mariani S, Genco A, Manfrini S, Lubrano C, Gnessi L (2020) Scientific evidence underlying contraindications to the ketogenic diet: an update. Obes Rev 21(10):e13053. https://doi.org/10.1111/obr.13053 (Epub 2020 Jul 10)
doi: 10.1111/obr.13053 pubmed: 32648647 pmcid: 7539910
Terzikhan N, Doets EL, Vonk N-SM (2015) Extensive literature search and review as preparatory work for the evaluation of the essential composition of total diet replacement products for weight control. EFSA Support Publ. https://doi.org/10.2903/sp.efsa.2015.EN-590
doi: 10.2903/sp.efsa.2015.EN-590
Moon J, Koh G (2020) Clinical evidence and mechanisms of high-protein diet-induced weight loss. J Obes Metab Syndr 29(3):166–173. https://doi.org/10.7570/jomes20028.PMID:32699189;PMCID:PMC7539343
doi: 10.7570/jomes20028.PMID:32699189;PMCID:PMC7539343 pubmed: 32699189 pmcid: 7539343
Pezzana A, Amerio ML, Fatati G et al (2014) La dieta chetogenica—fondazione ADI: position paper. ADI 6:38–43
Italian Standards for Treatment of Obesity, released by the Italian Society for the Study of Obesity (SIO) and the Italian Association of Dietetics and Clinical Nutrition (ADI) (2016–2017). https://www.sio-obesita.org/wp-content/uploads/2017/09/STANDARD-OBESITA-SIO-ADI.pdf . Accessed 28 Jun 2022
Wells JCK (2019) The diabesity epidemic in the light of evolution: insights from the capacity-load model. Diabetologia 62:1740–1750. https://doi.org/10.1007/s00125-019-4944-8
doi: 10.1007/s00125-019-4944-8 pubmed: 31451870 pmcid: 6731192
Kotz CM, Perez-Leighton CE, Teske JA, Billington CJ (2017) Spontaneous physical activity defends against obesity. Curr Obes Rep 6:362–370. https://doi.org/10.1007/s13679-017-0288-1
doi: 10.1007/s13679-017-0288-1 pubmed: 29101738 pmcid: 5716862
Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391:541–551. https://doi.org/10.1016/S0140-6736(17)33102-1
doi: 10.1016/S0140-6736(17)33102-1 pubmed: 29221645
Baker S, Jerums G, Proietto J (2009) Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes. Diabetes Res Clin Pract 85:235–242. https://doi.org/10.1016/j.diabres.2009.06.002
doi: 10.1016/j.diabres.2009.06.002 pubmed: 19560834
Malandrucco I, Pasqualetti P, Giordani I et al (2012) Very-low-calorie diet: a quick therapeutic tool to improve betacell function in morbidly obese patients with type 2 diabetes. Am J Clin Nutr 95:609–613. https://doi.org/10.3945/ajcn.111.023697
doi: 10.3945/ajcn.111.023697 pubmed: 22318758
Romano L, Marchetti M, Gualtieri P et al (2019) Effects of a personalized VLCKD on body composition and resting energy expenditure in the reversal of diabetes to prevent complications. Nutrients 11(7):1526. https://doi.org/10.3390/nu11071526
doi: 10.3390/nu11071526 pmcid: 6683248
Casanueva FF, Castellana M, Bellido et al (2020) Ketogenic diets as treatment of obesity and type 2 diabetes mellitus. Rev Endocr Metab Disord 21:381–397. https://doi.org/10.1007/s11154-020-09580-7
doi: 10.1007/s11154-020-09580-7 pubmed: 32803691
Hussain TA, Mathew TC, Dashti AA et al (2012) Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition 28:1016–1021. https://doi.org/10.1016/j.nut.2012.01.016
doi: 10.1016/j.nut.2012.01.016 pubmed: 22673594
Rafiullah M, Musambil M, David SK (2022) Effect of a very low-carbohydrate ketogenic diet vs recommended diets in patients with type 2 diabetes: a meta-analysis. Nutr Rev 80(3):488–502. https://doi.org/10.1093/nutrit/nuab040 (PMID: 34338787)
doi: 10.1093/nutrit/nuab040 pubmed: 34338787
Muscogiuri G, El Ghoch M, Colao A, Hassapidou M, Yumuk V, Busetto L, Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO) (2021) European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts 14(2):222–245. https://doi.org/10.1159/000515381 (Epub 2021 Apr 21. PMID: 33882506; PMCID: PMC8138199)
doi: 10.1159/000515381 pubmed: 33882506 pmcid: 8138199
Goday A, Bellido D, Sajoux I et al (2016) Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes 6(9):230. https://doi.org/10.1038/nutd.2016.36
doi: 10.1038/nutd.2016.36
Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42:731–754. https://doi.org/10.2337/dci19-0014
doi: 10.2337/dci19-0014 pubmed: 31000505 pmcid: 7011201
Moriconi E, Camajani E, Fabbri A et al (2021) Very-low-calorie ketogenic diet as a safe and valuable tool for long-term glycemic management in patients with obesity and type 2 diabetes. Nutrients. https://doi.org/10.3390/nu13030758
doi: 10.3390/nu13030758 pubmed: 34835951 pmcid: 8617652
Bruci A, Tuccinardi D, Tozzi R, Balena A, Santucci S, Frontani R, Mariani S, Basciani S, Spera G, Gnessi L, Lubrano C, Watanabe M (2020) Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure. Nutrients 12(2):333. https://doi.org/10.3390/nu12020333 (PMID:32012661; PMCID:PMC7071259)
doi: 10.3390/nu12020333 pmcid: 7071259
Watanabe M, Tozzi R, Risi R, Tuccinardi D, Mariani S, Basciani S, Spera G, Lubrano C, Gnessi L (2020) Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: a comprehensive review of the literature. Obes Rev 21(8):13024. https://doi.org/10.1111/obr.13024 (Epub 2020 Mar 24. PMID: 32207237; PMCID: PMC7379247)
doi: 10.1111/obr.13024
Castellana M, Conte E, Cignarelli A et al (2020) Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: a systematic review and meta-analysis. Rev Endocr Metab Disord 21:5–16. https://doi.org/10.1007/s11154-019-09514-y
doi: 10.1007/s11154-019-09514-y pubmed: 31705259
Locatelli CAA, Mulvihill EE (2020) Islet health, hormone secretion, and insulin responsivity with low-carbohydrate feeding in diabetes. Metabolites 10:455. https://doi.org/10.3390/metabo10110455
doi: 10.3390/metabo10110455 pmcid: 7697690
Rutter GA, Georgiadou E, Martinez-Sanchez A, Pullen TJ (2020) Metabolic and functional specialisations of the pancreatic beta cell: gene disallowance, mitochondrial metabolism and intercellular connectivity. Diabetologia 63:1990–1998. https://doi.org/10.1007/s00125-020-05205-5
doi: 10.1007/s00125-020-05205-5 pubmed: 32894309 pmcid: 7476987
O’Neill B, Raggi P (2020) The ketogenic diet: pros and cons. Atherosclerosis 292:119–126. https://doi.org/10.1016/j.atherosclerosis.2019.11.021
doi: 10.1016/j.atherosclerosis.2019.11.021 pubmed: 31805451
Kirkpatrick CF, Bolick JP, Kris-Etherton PM et al (2019) Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of bodyweight and other cardiometabolic risk factors: a scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. J Clin Lipidol 13:689–711. https://doi.org/10.1016/j.jacl.2019.08.003
doi: 10.1016/j.jacl.2019.08.003 pubmed: 31611148
Fung TT, Van Dam RM, Hankinson SE et al (2010) Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med 153:289–298. https://doi.org/10.7326/0003-4819-153-5-201009070-00003
doi: 10.7326/0003-4819-153-5-201009070-00003 pubmed: 20820038 pmcid: 2989112
Colberg SR, Sigal RJ, Fernhall B et al (2010) Exercise and Type 2 diabetes: the American college of sports medicine and the American diabetes association: joint position statement. Diabetes Care 33:e147–e167. https://doi.org/10.2337/dc10-9990
doi: 10.2337/dc10-9990 pubmed: 21115758 pmcid: 2992225
Monda V, Sessa F, Ruberto M (2020) Aerobic exercise and metabolic syndrome: the role of sympathetic activity and the redox system. Diabetes Metab Syndr Obes Targets Ther 13:2433–2442. https://doi.org/10.2147/DMSO.S257687
doi: 10.2147/DMSO.S257687
Wroble KA, Trott MN, Schweitzer GG et al (2019) Low-carbohydrate ketogenic diet impairs anaerobic exercise performance in exercise-trained women and men: a randomized-sequence crossover trial. J Sports Med Phys Fit 59:600–607. https://doi.org/10.23736/S0022-4707.18.08318-4
doi: 10.23736/S0022-4707.18.08318-4
Pilis K, Pilis A, Stec K et al (2018) Three-year chronic consumption of low-carbohydrate diet impairs exercise performance and has a small unfavorable effect on lipid profile in middle-aged men. Nutrients 10(12):1914. https://doi.org/10.3390/nu10121914
doi: 10.3390/nu10121914 pmcid: 6317154
Ferreira GA, Felippe LC, Silva RLS et al (2018) Effect of pre-exercise carbohydrate availability on fat oxidation and energy expenditure after a high-intensity exercise. Brazilian J Med Biol Res 51:1–8. https://doi.org/10.1590/1414-431X20186964
doi: 10.1590/1414-431X20186964
Burke LM, Ross ML, Garvican-Lewis LA et al (2017) Low carbohydrate, high fat diet impairs exercise economy and negates the performance benefit from intensified training in elite racewalkers. J Physiol 595:2785–2807. https://doi.org/10.1113/JP273230
doi: 10.1113/JP273230 pubmed: 28012184 pmcid: 5407976
Greene DA, Varley BJ, Hartwig TB et al (2018) A low-carbohydrate ketogenic diet reduces body mass without compromising performance in powerlifting and Olympic weightlifting athletes. J Strength Cond Res 32:3373–3382. https://doi.org/10.1519/JSC.0000000000002904
doi: 10.1519/JSC.0000000000002904 pubmed: 30335720
Paoli A, Grimaldi K, D’Agostino D et al (2012) Ketogenic diet does not affect strength performance in elite artistic gymnasts. J Int Soc Sports 9(1):34. https://doi.org/10.1186/1550-2783-9-34
doi: 10.1186/1550-2783-9-34
McSwiney FT, Wardrop B, Hyde PN et al (2018) Keto-adaptation enhances exercise performance and body composition responses to training in endurance athletes. Metabolism 81:25–34. https://doi.org/10.1016/j.metabol.2017.10.010
doi: 10.1016/j.metabol.2017.10.010 pubmed: 29108901
Heikura IA, Burke LM, Hawley JA et al (2020) A short-term ketogenic diet impairs markers of bone health in response to exercise. Front Endocrinol (Lausanne) 21(10):880. https://doi.org/10.3389/fendo.2019.00880
doi: 10.3389/fendo.2019.00880
Ranjan A, Schmidt S, Damm-Frydenberg C, Holst JJ, Madsbad S, Nørgaard K (2017) Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: a randomized open-label crossover trial. Diabetes Obes Metab 19(10):1479–1484. https://doi.org/10.1111/dom.12953 (Epub 2017 Jul 10 PMID: 28345762)
doi: 10.1111/dom.12953 pubmed: 28345762
Leow ZZX, Guelfi KJ, Davis EA, Jones TW, Fournier PA (2018) The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia. Diabet Med. https://doi.org/10.1111/dme.13663 (Epub ahead of print. PMID: 29737587)
doi: 10.1111/dme.13663 pubmed: 29737587
Bolla AM, Caretto A, Laurenzi A et al (2019) Low-carb and ketogenic diets in type 1 and type 2 diabetes. Nutrients 11(5):962. https://doi.org/10.3390/nu11050962
doi: 10.3390/nu11050962 pmcid: 6566854
Rondanelli M, Gasparri C, Peroni G, Faliva MA, Naso M, Perna S, Bazire P, Sajuox I, Maugeri R, Rigon C (2021) The potential roles of very low calorie, very low calorie ketogenic diets and very low carbohydrate diets on the gut microbiota composition. Front Endocrinol (Lausanne) 14(12):662591. https://doi.org/10.3389/fendo.2021.662591 (Erratum. In: FrontEndocrinol (Lausanne). 2021 Dec 22; 12:825790)
doi: 10.3389/fendo.2021.662591
Devaraj S, Hemarajata P, Versalovic J (2013) The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem 59:617–628. https://doi.org/10.1373/clinchem.2012.187617
doi: 10.1373/clinchem.2012.187617 pubmed: 23401286 pmcid: 3974587
Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG (2014) Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol 28:1221–1238. https://doi.org/10.1210/me.2014-1108
doi: 10.1210/me.2014-1108 pubmed: 24892638 pmcid: 5414803
Rastelli M, Knauf C, Cani PD (2018) Gut microbes and health: a focus on the mechanisms linking microbes, obesity, and related disorders. Obes (Silver Spring) 26:792–800. https://doi.org/10.1002/oby.22175
doi: 10.1002/oby.22175
Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W et al (2012) Host-gut microbiota metabolic interactions. Science. https://doi.org/10.1126/science.1223813
doi: 10.1126/science.1223813 pubmed: 22674330
Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, Miggiano GAD, Gasbarrini A, Mele MC (2019) Food components and dietary habits: keys for a healthy gut microbiota composition. Nutrients 11(10):2393. https://doi.org/10.3390/nu11102393
doi: 10.3390/nu11102393 pmcid: 6835969
Laterza L, Rizzatti G, Gaetani E, Chiusolo P, Gasbarrini A (2016) The gut microbiota and immune system relationship in human graft-versus-host disease. Mediterr J Hematol Infect Dis 8:e2016025. https://doi.org/10.4084/MJHID.2016.025
doi: 10.4084/MJHID.2016.025 pubmed: 27158438 pmcid: 4848019
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM et al (2011) Enterotypes of the human gut microbiome. Nature 473:174–180. https://doi.org/10.1038/nature09944
doi: 10.1038/nature09944 pubmed: 21508958 pmcid: 3728647
Brinkworth GD, Noakes M, Clifton PM, Bird AR (2009) Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 101:1493–1502. https://doi.org/10.1017/S0007114508094658
doi: 10.1017/S0007114508094658 pubmed: 19224658
Sergeev IN, Aljutaily T, Walton G, Huarte E (2020) Effects of synbiotic supplement on human gut microbiota, body composition and weight loss in obesity. Nutrients 12(1):222. https://doi.org/10.3390/nu12010222
doi: 10.3390/nu12010222 pmcid: 7019807
Gutierrez-Repiso C, Hernandez-Garcia C, Garcia-Almeida JM et al (2019) Effect of synbiotic supplementation in a very-low-Calorie ketogenic diet on weight loss achievement and gut microbiota: a randomized controlled pilot study. Mol Nutr Food Res 63(19):e1900167. https://doi.org/10.1002/mnfr.201900167
doi: 10.1002/mnfr.201900167 pubmed: 31298466
Di Rosa C, Lattanzi G, Taylor AF et al (2020) Very low calorie ketogenic diets in overweight and obesity treatment: effects on anthropometric parameters, body composition, satiety, lipid profile and microbiota. Obes Res Clin Pract 14:491–503. https://doi.org/10.1016/j.orcp.2020.08.009
doi: 10.1016/j.orcp.2020.08.009 pubmed: 32919928
Louis S, Tappu RM, Damms-Machado A, Huson DH, Bischoff SC (2016) Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLoS ONE 11(2):e0149564. https://doi.org/10.1371/journal.pone.0149564 (PMID:26919743; PMCID:PMC4769288)
doi: 10.1371/journal.pone.0149564 pubmed: 26919743 pmcid: 4769288
Basciani S, Camajani E, Contini S, Persichetti A, Risi R, Bertoldi L, Strigari L, Prossomariti G, Watanabe M, Mariani S, Lubrano C, Genco A, Spera G, Gnessi L (2020) Very-low-calorie ketogenic diets with whey, vegetable, or animal protein in patients with obesity: a randomized pilot study. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa336 (PMID: 32484877)
doi: 10.1210/clinem/dgaa336 pubmed: 32484877
Gutiérrez-Repiso C, Hernández-García C, García-Almeida JM, Bellido D, Martín-Núñez GM, Sánchez-Alcoholado L, Alcaide-Torres J, Sajoux I, Tinahones FJ, Moreno-Indias I (2019) Effect of synbiotic supplementation in a very-low-calorie ketogenic diet on weight loss achievement and gut microbiota: a randomized controlled pilot study. Mol Nutr Food Res 63(19):1900167. https://doi.org/10.1002/mnfr.201900167 (Epub 2019 Aug 29. PMID: 31298466)
doi: 10.1002/mnfr.201900167
Gutiérrez-Repiso C, Molina-Vega M, Bernal-López MR, Garrido-Sánchez L, García-Almeida JM, Sajoux I, Moreno-Indias I, Tinahones FJ (2021) Different weight loss intervention approaches reveal a lack of a common pattern of gut microbiota changes. J Pers Med 11(2):109. https://doi.org/10.3390/jpm11020109 (PMID:33567649; PMCID:PMC7915884)
doi: 10.3390/jpm11020109 pubmed: 33567649 pmcid: 7915884
Ang QY, Alexander M, Newman JC, Tian Y, Cai J, Upadhyay V, Turnbaugh JA, Verdin E, Hall KD, Leibel RL, Ravussin E, Rosenbaum M, Patterson AD, Turnbaugh PJ (2020) Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell 181(6):1263-1275.e16. https://doi.org/10.1016/j.cell.2020.04.027
doi: 10.1016/j.cell.2020.04.027 pubmed: 32437658 pmcid: 7293577
Paoli A, Mancin L, Bianco A et al (2019) Ketogenic diet and microbiota: friends or enemies? Genes (Basel) 10(7):534. https://doi.org/10.3390/genes10070534
doi: 10.3390/genes10070534
Cong L, Jianyun Z, Meiling L et al (2018) Alterations and structural resilience of the gut microbiota under dietary fat perturbations. J Nutr Biochem 61:91–100. https://doi.org/10.1016/j.jnutbio.2018.07.005
doi: 10.1016/j.jnutbio.2018.07.005
Morrison KE, Jaserevic E, Howard CD et al (2020) It’s the fiber, not the fat: significant effects of dietary challenge on the gut microbiome. Microbiome. https://doi.org/10.1186/s40168-020-0791-6
doi: 10.1186/s40168-020-0791-6 pubmed: 32046785 pmcid: 7014620

Auteurs

G Defeudis (G)

Unit of Endocrinology and Diabetes, Department of Medicine, University Campus Bio-Medico di Roma, Rome, Italy. g.defeudis@policlinicocampus.it.

M Rossini (M)

Diet and Diabetes Unit, ASL RM1, Rome, Italy.

Y M Khazrai (YM)

Unit of Food Science and Nutrition, Department of Science and Technology for Humans and the Environment, University Campus Bio-Medico di Roma, Rome, Italy.

A M V Pipicelli (AMV)

UOC di Nefrologia, Dialisi e Trapianto, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

G Brucoli (G)

Diet and Diabetes Unit, ASL RM1, Rome, Italy.

M Veneziano (M)

Diet and Diabetes Unit, ASL RM1, Rome, Italy.

F Strollo (F)

Endocrinology and Diabetes Unit, IRCCS San Raffaele Pisana, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH